Results     02-Jun-20
Announcements
Marksans Pharma consolidated net profit rises 333.91% in the March 2020 quarter
Sales rise 35.54% to Rs 335.35 crore
Net profit of Marksans Pharma rose 333.91% to Rs 42.74 crore in the quarter ended March 2020 as against Rs 9.85 crore during the previous quarter ended March 2019. Sales rose 35.54% to Rs 335.35 crore in the quarter ended March 2020 as against Rs 247.41 crore during the previous quarter ended March 2019.

For the full year,net profit rose 50.11% to Rs 120.75 crore in the year ended March 2020 as against Rs 80.44 crore during the previous year ended March 2019. Sales rose 13.41% to Rs 1134.21 crore in the year ended March 2020 as against Rs 1000.07 crore during the previous year ended March 2019.

ParticularsQuarter EndedYear Ended
 Mar. 2020Mar. 2019% Var.Mar. 2020Mar. 2019% Var.
Sales335.35247.41 36 1134.211000.07 13
OPM %20.636.33 -16.9513.21 -
PBDT67.1922.94 193 183.84127.11 45
PBT57.5616.68 245 157.17104.31 51
NP42.749.85 334 120.7580.44 50

Previous News
  Marksans Pharma consolidated net profit rises 14.97% in the June 2023 quarter
 ( Results - Announcements 12-Aug-23   07:46 )
  Marksans Pharma consolidated net profit rises 36.36% in the September 2023 quarter
 ( Results - Announcements 09-Nov-23   15:15 )
  USFDA concludes inspection of Time-Cap Laboratories' manufacturing facility in New York
 ( Corporate News - 28-Apr-25   12:58 )
  Marksans Pharma announces receipt of UKMHRA approval for Fluoxetine capsules
 ( Corporate News - 21-Aug-24   20:00 )
  Marksans Pharma gains as USFDA concludes inspection at New York unit
 ( Hot Pursuit - 28-Apr-25   11:56 )
  Marksans Pharma’s UK arm gets marketing nod for Oxybutynin Oral solution from UKMHRA
 ( Hot Pursuit - 19-Jun-25   10:04 )
  Marksans Pharma consolidated net profit rises 34.64% in the September 2022 quarter
 ( Results - Announcements 15-Nov-22   08:45 )
  Marksans Pharma hits 52 week high on receiving USFDA nod for pain relief tablets
 ( Hot Pursuit - 12-Jul-23   11:29 )
  Marksans Pharma receives affirmation in credit ratings
 ( Corporate News - 07-Feb-23   12:46 )
  Marksans Pharma receives USFDA approval for Acetaminophen and Ibuprofen Tablets
 ( Corporate News - 12-Jul-23   11:32 )
  Marksans Pharma to conduct board meeting
 ( Corporate News - 11-Jan-23   15:37 )
Other Stories
  Vasudhagama Enterprises consolidated net profit declines 86.67% in the March 2025 quarter
  30-Jun-25   07:28
  Mahesh Developers reports standalone net profit of Rs 0.05 crore in the March 2025 quarter
  28-Jun-25   07:32
  Maxgrow India reports standalone net loss of Rs 4.52 crore in the March 2025 quarter
  28-Jun-25   07:32
  Rose Merc. reports consolidated net loss of Rs 0.69 crore in the March 2025 quarter
  28-Jun-25   07:32
  NMS Global reports consolidated net profit of Rs 0.21 crore in the March 2025 quarter
  28-Jun-25   07:31
  GCCL Construction & Realities standalone net profit declines 46.67% in the March 2025 quarter
  27-Jun-25   07:34
  Konkan Railway Corporation standalone net profit declines 69.17% in the March 2025 quarter
  27-Jun-25   07:34
  Jorabat Shillong Expressway reports standalone net loss of Rs 10.15 crore in the March 2025 quarter
  27-Jun-25   07:34
  Rare Asset Reconstruction reports standalone net loss of Rs 2.46 crore in the March 2025 quarter
  27-Jun-25   07:34
  Prestige Projects Pvt standalone net profit declines 99.73% in the March 2025 quarter
  27-Jun-25   07:34
Back Top